GBIO
Generation Bio Co.
$5.43
+$0.04(+0.74%)
47
Overall
60
Value
50
Tech
31
Quality
Market Cap
$38.73M
Volume
14.16K
52W Range
$3.00 - $12.50
Target Price
$9.33
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | -- | -- | -- | $5.9M | $19.9M | ||
| Total Revenue | -- | -- | -- | $5.9M | $19.9M | ||
| GROSS PROFIT | |||||||
| Gross Profit | -- | -- | -- | $5.9M | $19.9M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $81.1M | $119.1M | $141.2M | $144.5M | $162.3M | ||
| Research & Development | $58.5M | $85.2M | $96.7M | $93.6M | $61.3M | ||
| Research Expense | $58.5M | $85.2M | $96.7M | $93.6M | $61.3M | ||
| Selling, General & Administrative | $22.6M | $33.9M | $44.5M | $50.9M | $37.8M | ||
| General & Administrative Expenses | $22.6M | $33.9M | $44.5M | $50.9M | $37.8M | ||
| Salaries & Wages | -- | -- | $24.5M | $24.3M | $14.6M | ||
| Depreciation & Amortization | $3.4M | $4.5M | $5.1M | $5.3M | $4.9M | ||
| Depreciation & Amortization | $3.4M | $4.5M | $5.1M | $5.3M | $4.9M | ||
| Other Operating Expenses | $81.1M | $8.4M | $16.4M | $144.5M | $162.3M | ||
| OPERATING INCOME | |||||||
| Operating income | $-81.1M | $-119.1M | $-141.2M | $-138.6M | $-142.4M | ||
| EBITDA | $-77.7M | $-114.6M | $-131.5M | $-121.3M | $-126.7M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | -- | $50.0K | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | -- | -- | $-4.5M | $-12.0M | -- | ||
| Other Income/Expense | $-591.0K | $50.0K | $-4.5M | $-12.0M | $52.5M | ||
| Other Special Charges | $591.0K | $-50.0K | $4.5M | $12.0M | $10.7M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | -- | -- | -- | $7.0M | $-401.0K | ||
| Special Income Charges | -- | -- | -- | $-7.0M | $401.0K | ||
| Other Impairment Of Capital Assets | -- | -- | $5.8M | -- | $45.8M | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-81.1M | $-119.1M | $-136.6M | $-126.6M | $-131.7M | ||
| Pre-Tax Income | $-80.5M | $-119.2M | $-136.6M | $-126.6M | $-131.7M | ||
| INCOME TAX | |||||||
| Tax Provision | $27.9M | -- | -- | -- | -- | ||
| NET INCOME | |||||||
| Net Income | $-80.5M | $-119.2M | $-136.6M | $-126.6M | $-131.7M | ||
| Net Income (Continuing Operations) | $-80.5M | $-119.2M | $-136.6M | $-126.6M | $-131.7M | ||
| Net Income (Discontinued Operations) | $-80.5M | $-119.2M | $-136.6M | $-126.6M | $-131.7M | ||
| Net Income (Common Stockholders) | $-80.5M | $-119.2M | $-136.6M | $-126.6M | $-131.7M | ||
| TOTALS | |||||||
| Total Expenses | $81.1M | $119.1M | $141.2M | $144.5M | $162.3M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $2.7M | $5.6M | $5.8M | $6.4M | $66.6M | ||
| Average Shares Outstanding (Diluted) | $2.7M | $5.6M | $5.8M | $6.4M | $66.6M | ||
| Shares Outstanding | $5.6M | $5.7M | $6.0M | $6.6M | $67.0M | ||
| Basic EPS | $-29.5 | $-21.2 | $-23.5 | $-19.6 | $-1.98 | ||
| Basic EPS (Continuing Operations) | $-29.5 | $-21.2 | $-23.5 | $-19.6 | $-1.98 | ||
| Diluted EPS | $-29.5 | $-21.2 | $-23.5 | $-19.6 | $-1.98 | ||
| Diluted EPS (Continuing Operations) | -- | $-21.2 | $-23.5 | $-19.6 | $-1.98 | ||
| OTHER METRICS | |||||||
| Gain On Sale Of P P E | -- | -- | -- | -- | $-63.2M | ||
| Other Gand A | $22.6M | $33.9M | $44.5M | $50.9M | $37.8M | ||
| Rent And Landing Fees | $7.5M | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | $7.0M | $-401.0K | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GBIO | $5.43 | +0.7% | 14.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |